ARXIS INC-A
ARXS · NASDAQ
更新於 2026-10-13 14:04:20
- 今日最高
- $49.08
- 今日最低
- $45.93
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $47.99
- 昨天收盤價
- $47.78
- 成交量
- 843.77K
- 市值
- $20.58B
- 市盈率（P/E）
- --
- 每股收益（EPS）
- --
昨天價格區間
52週價格區間
公司概況
- 板塊
- 工業
- 行業
- 航空航天與國防
- 子行業
- 航空航天與國防
- 總部
- 1332 BLUE HILLS AVENUE, BLOOMFIELD, CT, UNITED STATES, 06002
- 國家
- 美國
- 上市日期
- 2026-04-16
- 財年截止
- 十二月
- 流通股數
- 417.47M
- CIK
- --
- 官方網址
- www.arxis.com
Arxis, Inc.（ARXS）是一家充滿活力的生物科技公司，專注為複雜疾病開發尖端療法，並憑藉穩健的研發框架。憑藉針對罕見病及常見病的多元化藥物管道，Arxis 重視策略合作及全面臨床計劃，以推動創新並改善患者治療結果。隨著關鍵臨床試驗階段推進，公司具備實現大幅增長及價值創造的有利條件，使其成為快速演變的生物科技領域中對機構投資者具吸引力的選擇。
財務指標
營業收入
2026-06-30
$500.72M
2026-03-31
$458.85M
2025-06-30
$400.44M
2025-03-31
$380.07M
營業支出
2026-06-30
$229.91M
2026-03-31
$124.34M
2025-06-30
$317.59M
2025-03-31
$319.87M
淨利潤
2026-06-30
-$4.9M
2026-03-31
$53.3M
2025-06-30
-$29.25M
2025-03-31
-$4.32M
淨利潤率
2026-06-30
-0.98%
2026-03-31
11.61%
2025-06-30
-7.3%
2025-03-31
-1.13%
每股收益
2026-06-30
$0.08
2026-03-31
$0.12
2025-06-30
--
2025-03-31
--
息稅折舊攤銷前利潤
2026-06-30
$90.04M
2026-03-31
$164.49M
2025-06-30
$135.54M
2025-03-31
$110.42M
有效稅率
2026-06-30
-247.17%
2026-03-31
22.75%
2025-06-30
--
2025-03-31
--
| 項目 | 2026-06-30 | 2026-03-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| 營業收入 | $500.72M | $458.85M | $400.44M | $380.07M |
| 營業支出 | $229.91M | $124.34M | $317.59M | $319.87M |
| 淨利潤 | -$4.9M | $53.3M | -$29.25M | -$4.32M |
| 淨利潤率 | -0.98% | 11.61% | -7.3% | -1.13% |
| 每股收益 | $0.08 | $0.12 | -- | -- |
| 息稅折舊攤銷前利潤 | $90.04M | $164.49M | $135.54M | $110.42M |
| 有效稅率 | -247.17% | 22.75% | -- | -- |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。